A*STAR researchers identify a novel mechanism in which an inflammatory protein heals wounds in healthy individuals but has the opposite effect in diabetics.
Controlling the delicate balance between immune cells called granulocytes and monocytes could make the difference between a healthy immune response and life-threatening sepsis.
In a classic case of double trouble, the binding of SARS-CoV-2’s spike protein to bacterial lipopolysaccharide supercharges inflammation in COVID-19 patients.
These novel immune signatures identify patients most at risk for developing severe COVID-19 symptoms.
Lisa F. P. Ng, a leading infectious disease expert on infection and immunity, shares how her team’s prior experience has helped them quickly understand the nature of SARS-CoV-2, the virus that causes COVID-19.
A*STAR scientists can now classify immune cell populations with greater precision thanks to a machine-learning algorithm.
A*STAR scientists have identified a molecular marker for tracing the origins of immune cells that reside in tissues and organs.
Targeted mutagenesis is being used to create live-attenuated vaccines against the chikungunya virus.
Recent progress in our understanding of Malassezia fungi is helping to unlock the secrets of their role in human health and disease.
Malaria infections may be masking the extent of the emerging chikungunya epidemic
White blood cells in different subsets have varying propensities to fuse in response to inflammation